The financial picture for companies across the health insurer industry is looking grim, with uncertainty at a time when investors hoped their finances would be steadying after a challenging 2024, Anna Wilde Mathews of The Wall Street Journal reports. Moline Healthcare (MOH) recently warned of higher medical costs to hit earnings this year while Centene (CNC) withdrew its FY25 guidance, saying profits would fall short of its prior expectations. With new legislation and certain federal subsidies set to drop next year, about 17M people are no longer going to be covered by Medicaid and the ACA marketplaces, both of which are a focus for Centene and Molina. Publicly traded companies in the space include CVS Health (CVS), Cigna (CI), Elevance Health (ELV), Humana (HUM), and UnitedHealth (UNH).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- JPMorgan says too early to conclude other MCOs exposed to same risk as Centene
- Closing Bell Movers: Centene down 24% after pulling 2025 guidance
- Wells says OBBBA incrementally positive for managed care, uncertainty still high
- Wiley appoints Cigna chief digital, analytics officer Katya Andresen to board
- Supreme Court keeps element of Obamacare preventive care, Reuters reports